Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors
Authors:
- 16 October 2003
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 32 (9) , 881-887
Abstract
The aim of this study was to identify the risk factors for acute graft-versus-host disease (aGVHD) in children transplanted from a matched-sibling donor (MSD) or an unrelated donor (UD). In all, 87 children consecutively underwent allogeneic bone marrow transplantation (BMT) from MSD (n=36), and UD (n=51). GVHD prophylaxis included CsA alone (n=33) or with MTX (n=51). ATG was added in UD-BMT and thalassemic recipients. CsA whole-blood concentrations were measured by EMIT and the dosing regimen was monitored by Bayesian pharmacokinetic modelling. Trough blood concentration (TBC) during the first 2 weeks post transplantation was lower in children who developed grade II–IV aGVHD than those developing no GVHD or only grade I (579 vs 948 ng/ml, P=0.007), whereas peak blood concentration and area under concentration curve vs time were similar in both groups. TBC P=0.003 and 0.007, respectively) as well as in UD-SCT (P=0.006 and 0.003). Donor age 8 years was significant only in MSD-BMT. Our results have shown the significant decisive role of pharmacological factors such as CSA TBC or use of MTX in the occurrence of GVHD in MSD as well as in UD paediatric BMT.Keywords
This publication has 29 references indexed in Scilit:
- Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in childrenBone Marrow Transplantation, 2001
- Unrelated donor bone marrow transplantation for children with acute leukemia.Journal of Clinical Oncology, 1997
- Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remissionBritish Journal of Haematology, 1996
- The Highest Leukaemia-Free Survival After Allogeneic Bone Marrow Transplantation is Seen in Patients with Grade I Acute Graft-Versus-Host DiseaseLeukemia & Lymphoma, 1996
- Unrelated donor marrow transplantation in childrenBlood, 1995
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]Blood, 1989
- A Randomized Study of the Prevention of Acute Graft-versus-Host DiseaseNew England Journal of Medicine, 1982
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979
- Severe Combined Immunodeficiency DiseaseJAMA, 1977